Form 4: Lexicon Pharmaceuticals Executive Brian T. Crum Reports Stock Option and Restricted Stock Unit Grants

Brian T. Crum, SVP, General Counsel & Secretary of Lexicon Pharmaceuticals, reports the acquisition of stock options and restricted stock units.

Summary

• On February 13, 2025, Brian T. Crum, SVP, General Counsel & Secretary of Lexicon Pharmaceuticals, acquired stock options for 765,730 shares of common stock at an exercise price of $0.695.
• These options vest 25% on the first anniversary of the grant date and then 1/48th per month thereafter.
• Crum also acquired 510,490 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock.
• These RSUs vest in three equal installments on February 28 of each of the three years following the year of grant.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options and RSUs is a standard practice and generally viewed as a positive sign of aligning management interests with shareholders. There are no immediate negative implications.

Positives

• The grant of stock options and RSUs to a key executive like Brian T. Crum aligns his interests with those of the shareholders.
• The vesting schedules encourage long-term commitment and performance.

Industry Context

Stock option and RSU grants are common forms of executive compensation in the pharmaceutical industry, used to incentivize performance and retain key personnel.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are standard practice in the pharmaceutical industry.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize similar equity-based compensation to align executive interests with shareholder value.
• The vesting schedules (25% after one year, then monthly for options; annual vesting for RSUs) are fairly typical.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign of aligning management interests with long-term company performance.
• Employees may be motivated by the potential for future equity grants.

Key Dates